Invention Grant
- Patent Title: Atropisomerism for enhanced kinase inhibitor selectivity
-
Application No.: US16624972Application Date: 2018-06-21
-
Publication No.: US10934300B2Publication Date: 2021-03-02
- Inventor: Jeffrey L. Gustafson , Sean T. Toenjes , Sean M. Maddox
- Applicant: San Diego State University Foundation , Jeffrey L. Gustafson , Sean T. Toenjes , Sean M. Maddox
- Applicant Address: US CA San Diego; US CA San Diego; US CA San Diego; US CA San Diego
- Assignee: San Diego State University Foundation,Jeffrey L. Gustafson,Sean T. Toenjes,Sean M. Maddox
- Current Assignee: San Diego State University Foundation,Jeffrey L. Gustafson,Sean T. Toenjes,Sean M. Maddox
- Current Assignee Address: US CA San Diego; US CA San Diego; US CA San Diego; US CA San Diego
- Agency: Haukaas Fortius PLLC
- Agent Michael H. Haukaas
- International Application: PCT/US2018/038737 WO 20180621
- International Announcement: WO2018/237134 WO 20181227
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519

Abstract:
The invention provides a series of conformationally stable and selective kinase inhibitors, and methods of using the kinase inhibitors. The effect of atropisomerism on kinase selectivity was assessed, finding improved selectivity compared to rapidly interconverting parent compounds. The compounds herein are atropisomers having increased kinase selectivity, and are for use in treating conditions that benefit from selective kinase inhibition.
Public/Granted literature
- US20200165258A1 ATROPISOMERISM FOR ENHANCED KINASE INHIBITOR SELECTIVITY Public/Granted day:2020-05-28
Information query